BIOMAT Database Logo BIOMAT Database Logo

Incomplete transformation of plasma fibrinogen to fibrin. Fibrinogen content and streptokinase-induced intra-clot lysis susceptibility of des-AA or des-AABB fibrin clots formed at varying fibrinogen/fibrin ratios. 1979

F Brosstad, and H C Godal

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

F Brosstad, and H C Godal
Different chromatographic behaviour of soluble, non-FSF-stabilized des-AA fibrin/fibrinogen and des-AABB fibrin/fibrinogen complexes.
January 1979, Thrombosis research,
F Brosstad, and H C Godal
Lower susceptibility of human des-AA versus des-AABB fibrin towards fibrin stabilizing factor.
November 1978, Thrombosis research,
F Brosstad, and H C Godal
Discrepant elimination of fibrin des-AA and des-AABB in man.
June 1986, Thrombosis and haemostasis,
F Brosstad, and H C Godal
The effect of fibrinogen concentration on susceptibility of clots to in vitro clot lysis with plasmin.
September 1958, Thrombosis et diathesis haemorrhagica,
F Brosstad, and H C Godal
Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis.
December 2009, Thrombosis and haemostasis,
F Brosstad, and H C Godal
Lysis of arterial clot by intravenous or intra-arterial administration of streptokinase.
February 1984, Surgery, gynecology & obstetrics,
F Brosstad, and H C Godal
Fibrinogen-fibrin related antigen pattern in human blood. Incomplete lysis of whole blood clots by urokinase.
April 1975, Thrombosis research,
F Brosstad, and H C Godal
Urokinase-induced fibrin clot lysis and its inhibition by plasma.
January 1980, Upsala journal of medical sciences,
F Brosstad, and H C Godal
Fibrinolysis of soluble and polymerized des-AA/des-AABB fibrin compared to fibrinogenolysis in buffer and in fibrinogen-boosted serum. Evidence that plasminogen activators are responsible for preferential degradation of polymerized fibrin.
January 1979, Thrombosis research,
F Brosstad, and H C Godal
Comparison of the in vivo clearance of des-AA and des-AABB rat fibrin monomers prepared by different methods.
April 1982, Biochemical and biophysical research communications,
Copied contents to your clipboard!